WO2006084894A3 - Verwendung von tryptophan in kombination mit koffein und taurin, nahrungsmittel und getränk diese kombination enthaltend - Google Patents

Verwendung von tryptophan in kombination mit koffein und taurin, nahrungsmittel und getränk diese kombination enthaltend Download PDF

Info

Publication number
WO2006084894A3
WO2006084894A3 PCT/EP2006/050830 EP2006050830W WO2006084894A3 WO 2006084894 A3 WO2006084894 A3 WO 2006084894A3 EP 2006050830 W EP2006050830 W EP 2006050830W WO 2006084894 A3 WO2006084894 A3 WO 2006084894A3
Authority
WO
WIPO (PCT)
Prior art keywords
combination
tryptophan
taurine
caffeine
foodstuff
Prior art date
Application number
PCT/EP2006/050830
Other languages
English (en)
French (fr)
Other versions
WO2006084894A2 (de
Inventor
Patrick Faber
Original Assignee
Patrick Faber
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Patrick Faber filed Critical Patrick Faber
Publication of WO2006084894A2 publication Critical patent/WO2006084894A2/de
Publication of WO2006084894A3 publication Critical patent/WO2006084894A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Die Erfindung betrifft eine Verwendung von Tryptophan zur Verbesserung der kognitiven Leistungsfähigkeit, wobei Tryptophan zusammen mit Koffein und Taurin verabreicht wird.
PCT/EP2006/050830 2005-02-10 2006-02-10 Verwendung von tryptophan in kombination mit koffein und taurin, nahrungsmittel und getränk diese kombination enthaltend WO2006084894A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005006241A DE102005006241A1 (de) 2005-02-10 2005-02-10 Verwendung von Tryptophan, Nahrungsmittel und Getränk
DE102005006241.5 2005-02-10

Publications (2)

Publication Number Publication Date
WO2006084894A2 WO2006084894A2 (de) 2006-08-17
WO2006084894A3 true WO2006084894A3 (de) 2007-04-12

Family

ID=36564774

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/050830 WO2006084894A2 (de) 2005-02-10 2006-02-10 Verwendung von tryptophan in kombination mit koffein und taurin, nahrungsmittel und getränk diese kombination enthaltend

Country Status (2)

Country Link
DE (1) DE102005006241A1 (de)
WO (1) WO2006084894A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2869720B1 (de) 2012-11-02 2018-04-25 DSM IP Assets B.V. Verwendung von tryptophan-reichen proteinhydrolysaten
EP2737809A1 (de) 2012-12-03 2014-06-04 MüMed Aminosäurehaltiges Getränk, geeignet zur Verwendung in der Prophylaxe und Behandlung von psychischen Störungen
PL233564B1 (pl) * 2017-01-30 2019-10-31 La Sad Trade Spolka Z Ograniczona Odpowiedzialnoscia Prozdrowotny owocowy napój energetyczny i sposób jego wytwarzania
EP3991573A1 (de) 2020-11-03 2022-05-04 Patrick Faber Zusammensetzungen zur nasalen applikation
CN114822143B (zh) * 2022-06-29 2022-09-02 深圳前海壹路科技有限公司 军事训练智能考核管理系统和方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1222861A1 (de) * 2000-12-22 2002-07-17 Nabuurs Groep B.V. Antemortem Zusatz für Tiere

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2826808B2 (ja) * 1995-07-14 1998-11-18 カルピス株式会社 脳機能改善、学習能力増強および記憶力増強作用を有する機能性食品
WO1999061038A1 (en) * 1998-05-29 1999-12-02 Adams Food Ltd. Composition having therapeutic and/or nutritionally active substituent
US20010008641A1 (en) * 1998-11-25 2001-07-19 R. Douglas Krotzer Nutritionally active composition for bodybuilding
US6261589B1 (en) * 1999-03-02 2001-07-17 Durk Pearson Dietary supplement nutrient soft drink composition with psychoactive effect
WO2003101225A1 (en) * 2002-05-31 2003-12-11 Suomen Ravitsemusinstituutti Oy A drink composition and a method for composing a drink

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1222861A1 (de) * 2000-12-22 2002-07-17 Nabuurs Groep B.V. Antemortem Zusatz für Tiere

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MARKUS C ROB ET AL: "Whey protein rich in alpha-lactalbumin increases the ratio of plasma tryptophan to the sum of the other large neutral amino acids and improves cognitive performance in stress-vulnerable subjects", AMERICAN JOURNAL OF CLINICAL NUTRITION, vol. 75, no. 6, June 2002 (2002-06-01), pages 1051 - 1056, XP002385035, ISSN: 0002-9165 *
SEIDL R ET AL: "A taurine and caffeine-containing drink stimulates cognitive performance and well-being", AMINO ACIDS (VIENNA), vol. 19, no. 3-4, 2000, pages 635 - 642, XP002385036, ISSN: 0939-4451 *

Also Published As

Publication number Publication date
WO2006084894A2 (de) 2006-08-17
DE102005006241A1 (de) 2006-08-17

Similar Documents

Publication Publication Date Title
WO2005097825A3 (en) Bmp-7 variants with improved properties
AU303564S (en) Container and cap
EP2532657A3 (de) Verbindungen und anwendungsverfahren
WO2006105338A3 (en) Fc VARIANTS WITH OPTIMIZED PROPERTIES
CA117891S (en) Combined bottle and cap
WO2007076423A3 (en) INHIBITORS OF Akt ACTIVITY
IL185042A0 (en) Non-alcoholic beverage enriched with 1h2 16o
WO2008082561A3 (en) Mixtures of ammonia and ionic liquids
WO2007118610A8 (de) Kohlenhydrathaltige sportgetränke
EP1888091A4 (de) Verwendung des reizenden prinzips oleocanthal in olivenöl sowie strukturell und funktionell ähnlicher verbindungen
WO2007057018A3 (en) Glucoamylase variants
WO2005117979A3 (en) Use of il-17 in the treatment of fertility-related disorders
WO2006084894A3 (de) Verwendung von tryptophan in kombination mit koffein und taurin, nahrungsmittel und getränk diese kombination enthaltend
AU2014210581B2 (en) Probiotics for use in relieving symptoms associated with gastrointestinal disorders
EP1938699A4 (de) Flüssigkeitsextrakt mit kryptoxanthin-anteil sowie nahrungsmittel oder getränk und seife oder kosmetikartikel mit diesem flüssigkeitsextrakt
CA121128S (en) Container
AU304022S (en) Bottle cap
EP2119367A4 (de) Öl-und-fett-zusammensetzung sowie nahrungsmittel oder getränk, das die öl-und-fett-zusammensetzung enthält
ZA201000581B (en) 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazepine-7-carboxamide derivatives,preparation and therapeutic use thereof
WO2007076320A3 (en) Compounds
WO2009059239A3 (en) REDUCING Aβ42 LEVELS AND Aβ AGGREGATION
EP1724341A4 (de) Neuartiges, die geschmackswahrnehmung modifizierendes peptid nas, dessen dna und dessen verwendung
DK1922320T3 (da) Derivater af 5-pyridazinyl-1-azabicyclo[3.2.1]octan, fremstilling deraf og anvendelse deraf i terapi
EP1784199A4 (de) Verbindungen zur behandlung von marihuana-abhängigkeit, entzug und konsum
AU301987S (en) Writing utensil

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: FESTSTELLUNG EINES RECHTSVERLUSTS NACH REGEL 112(1) EPUE, EPA FORM 1205A VOM 11.12.07.

122 Ep: pct application non-entry in european phase

Ref document number: 06708173

Country of ref document: EP

Kind code of ref document: A2